Mission

BioAdvance is an evergreen fund that provides early-stage capital for companies in the mid-Atlantic region developing technologies to enhance human health. Comprised of a team of experienced business executives, scientists, physicians, and entrepreneurs, BioAdvance actively collaborates with startups to ensure their growth and success. The fund has a strong portfolio that has attracted over $4.2 billion in follow-on funding, enabling significant advancements in the life sciences including therapeutics, medical devices, research tools, diagnostics, and health IT.